Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
34 participants
INTERVENTIONAL
2024-11-04
2025-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transient and Immediate Motor Effects of Exercise in Progressive Multiple Sclerosis
NCT05562414
Exercise Intensity and Immune Function in Multiple Sclerosis
NCT02264704
Ischemic Preconditioning, Exercise Tolerance and Multiple Sclerosis
NCT03153553
Exercise to Manage Fatigue in Progressive Multiple Sclerosis
NCT04304027
Effect of Resistance Training on Psychophysiological Indicators in People With Multiple Sclerosis
NCT07118514
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Training Group
Intrinsic Mucle Training
Conventional physiotherapy treatment and the intrinisc foot muscles strengthening program for 8 weeks.
Control Group
Intrinsic Mucle Training
Conventional physiotherapy treatment and the intrinisc foot muscles strengthening program for 8 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intrinsic Mucle Training
Conventional physiotherapy treatment and the intrinisc foot muscles strengthening program for 8 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Diagnosis of visual or vestibular disorders that could affect patient stability
* Change in Multiple Sclerosis-specific medication in the 2 months prior to the start of the study
* Acute relapse in the 2 months prior to the start of the study
* Traumatologic or orthopaedic disorders that could negatively affect balance.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Inés Llamas-Ramos
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Inés Llamas-Ramos
PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad de Valladolid
Valladolid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Daniel García García, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FOOT TRAINING-SCLEROSIS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.